Multi-centre phase IV trial to investigate the immunogenicity of a new liquid formulation of recombinant human growth hormone in adults with growth hormone deficiency. [electronic resource]
Producer: 20181106Description: 919-927 p. digitalISSN:- 1720-8386
- Adult
- Aged
- Antibodies, Neutralizing -- chemistry
- Biological Availability
- Biomarkers -- analysis
- Female
- Follow-Up Studies
- Growth Disorders -- drug therapy
- Human Growth Hormone -- administration & dosage
- Humans
- Lipids -- chemistry
- Male
- Middle Aged
- Prognosis
- Recombinant Proteins -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.